A combined epidemiologic and metabolomic approach improves CKD prediction.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2013-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1681/ASN.2012101006PMID 23687356PMCID PMC3736702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma metabolomic profiles in different stages of CKD.

  2013cited by this paper
• Serum metabolite concentrations and decreased GFR in the general population.

  2012cited by this paper
• Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3.

  2012cited by this paper
• Estimating glomerular filtration rate from serum creatinine and cystatin C.

  2012cited by this paper
• Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans.

  2011cited by this paper
• Metabolite profiles and the risk of developing diabetes

  2011cited by this paper
• Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

  2011cited by this paper
• Metabolomic analysis of human plasma from haemodialysis patients

  2011cited by this paper
• Kynurenine is an endothelium-derived relaxing factor produced during inflammation

  2010cited by this paper
• Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

  2010cited by this paper
• Metabolomic profiling of uremic solutes in CKD patients

  2010cited by this paper
• Metabolite profiling identifies markers of uremia.

  2010cited by this paper
• SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation.

  2009cited by this paper
• Control of choline oxidation in rat kidney mitochondria.

  2009cited by this paper
• Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow Conditions*

  2009cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury.

  2008cited by this paper
• Thematic Review Series: Glycerolipids. Phosphatidylcholine and choline homeostasis Published, JLR Papers in Press, January 19, 2008.

  2008cited by this paper
• The human indoleamine 2,3-dioxygenase gene and related human genes.

  2007cited by this paper
• Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.

  2005cited by this paper
• Renal metabolism of amino acids: its role in interorgan amino acid exchange.

  2004cited by this paper
• The SLC22 drug transporter family

  2004cited by this paper
• Predictors of new-onset kidney disease in a community-based population.

  2004cited by this paper
• Goodpasture syndrome during the course of a Schönlein-Henoch purpura.

  2002cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Determination of choline dehydrogenase activity along the rat nephron.

  1996cited by this paper
• Tubulointerstitial changes as a major determinant in the progression of renal damage.

  1992cited by this paper
• Accumulation of glycero-phosphocholine (GPC) by renal cells: Osmotic regulation of GPC:choline phosphodiesterase

  1991cited by this paper
• Localization of arginine synthesis along rat nephron.

  1990cited by this paper
• Renal arginine synthesis: studies in vitro and in vivo.

  1990cited by this paper
• Serum creatinine and renal function.

  1988cited by this paper
• Renal substrate metabolism.

  1986cited by this paper
• Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency.

  1980cited by this paper
• An investigation of coronary heart disease in families. The Framingham offspring study.

  1979cited by this paper
• Amino acid extraction and ammonia metabolism by the human kidney during the prolonged administration of ammonium chloride.

  1963cited by this paper

• Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study.

  2026cites this paper
• The effect of elevated levels of the gut metabolite TMAO on glucose metabolism after sleeve gastrectomy

  2025cites this paper
• Metabolomics reveals alterations in gut-derived uremic toxins and tryptophan metabolism in feline chronic kidney disease

  2025influential citation
• Early detection of feline chronic kidney disease via 3-hydroxykynurenine and machine learning

  2025cites this paper
• The microbiome-derived metabolite trimethylamine N-oxide is associated with chronic kidney disease risk

  2025influential citation
• Identification of progression-related genes and construction of prognostic model for chronic kidney disease by machine learning

  2025cites this paper
• Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger‐onset type 2 diabetes

  2025cites this paper
• Associations of Plasma Trimethylamine N-Oxide-Related Metabolites with the Development and Progression of Albuminuria: The Multi-Ethnic Study of Atherosclerosis.

  2025cites this paper
• Methylamine metabolites and progression to kidney failure in type 2 diabetes: an Asian and European prospective study.

  2025cites this paper
• A Metabolomics Study of Cardiac Dysfunction in Hyperglycemia: Findings From the Atherosclerosis Risk in Communities (ARIC) Study and the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

  2025cites this paper
• Metabolomics in sickle cell disease: Current knowledge and gaps - A scoping review.

  2025cites this paper
• Bidirectional Association of Gut Microbiota-Derived Trimethylamine N-Oxide and its Precursors with Estimated Glomerular Filtration Rate: A Cross-Lagged Cohort Study.

  2025cites this paper
• Future Directions in Choline: From Neurodevelopment to Cardiometabolic Health

  2025cites this paper
• Renal Arteriovenous Gradients for Greater Than 10,000 Circulating Proteins.

  2025cites this paper
• Plasma and Urine Metabolites Associated With Nondiabetic Chronic Kidney Disease: The HELIUS Study

  2025cites this paper
• Trimethylamine N-oxide (TMAO) for risk stratification after acute ischemic stroke: Results from the BIOSIGNAL cohort study.

  2025cites this paper
• Toward precision nephrology: identification of cause-specific chronic kidney disease biomarkers through multiomics integration in Korean cohorts

  2025cites this paper
• The role of the urinary microbiome in diabetes-associated UTIs: current understanding and future directions

  2025cites this paper
• Integrated genomics and metabolomics to identify cause-specific biomarkers for chronic kidney disease in a Korean population

  2025cites this paper
• Utility of trimethylamine N-oxide (TMAO) as a biomarker for risk stratification in chronic kidney disease: a multicenter observational study

  2025influential citation
• Association of Dietary Micronutrient Intake and the Metabolome in Children with Chronic Kidney Disease.

  2025cites this paper
• Metabolomics for the Identification of Biomarkers in Kidney Diseases

  2025cites this paper
• Urine choline oxidation metabolites predict chronic kidney disease progression in patients with type 2 diabetes.

  2025cites this paper
• Plasma Trimethylamine N‐Oxide Levels in Nondialysis Chronic Kidney Disease Patients Following Meal Challenge

  2025cites this paper
• Deficiency of flavin-containing monooxygenase 3 protects kidney function after ischemia–reperfusion in mice

  2024cites this paper
• Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis

  2024cites this paper
• Metabolic Crosstalk in Multimorbidity: Identifying Compensatory Effects Among Diabetes, Hypertension, and Dyslipidemia

  2024cites this paper
• Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition.

  2024cites this paper
• Amino acid metabolism in kidney health and disease

  2024cites this paper
• Revealing novel biomarkers for diagnosing chronic kidney disease in pediatric patients

  2024cites this paper
• Causality of Genetically Determined Metabolites on Chronic Kidney Disease: A Two-Sample Mendelian Randomization Study In Silico

  2024cites this paper
• Serum and Urine Metabolites and Kidney Function

  2024cites this paper
• Integrated Proteomic and Metabolomic Modules associated with Risk of Kidney Disease Progression.

  2024cites this paper
• Downregulation of the kidney glucagon receptor, essential for renal function and systemic homeostasis, contributes to chronic kidney disease.

  2024cites this paper
• Interpretable machine learning identifies metabolites associated with glomerular filtration rate in type 2 diabetes patients

  2024cites this paper
• The gut microbe-derived metabolite trimethylamine N-oxide in patients with systemic lupus erythematosus

  2024cites this paper
• Gastric Fluid Metabolomics Predicting the Need for Surfactant Replacement Therapy in Very Preterm Infants Results of a Case–Control Study

  2024cites this paper
• Plasma Proteins Associated with Chronic Histopathologic Lesions on Kidney Biopsy

  2024cites this paper
• Targeted metabolomics identified novel metabolites, predominantly phosphatidylcholines and docosahexaenoic acid-containing lipids, predictive of incident chronic kidney disease in middle-to-elderly-aged Chinese adults.

  2024cites this paper
• Metabolomics to Identify Unclassified Uremic Toxins: A Comprehensive Literature Review

  2024cites this paper
• The human gut microbiome in health and disease: time for a new chapter?

  2024cites this paper
• Early Metabolomic Profiling as a Predictor of Renal Function Six Months After Kidney Transplantation

  2024cites this paper
• The Gut Microbial Metabolite Trimethylamine N-oxide, Incident CKD, and Kidney Function Decline

  2024cites this paper
• NAD+ enhancers as therapeutic agents in the cardiorenal axis

  2024cites this paper
• Plasma Tryptophan-Kynurenine Pathway Metabolites and Risk for Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes

  2023cites this paper
• Prognostic Significance of Amino Acid and Biogenic Amines Profiling in Chronic Kidney Disease

  2023cites this paper
• A Deeper Dive Into Lipid Alterations in CKD.

  2023cites this paper
• Tryptophan Metabolites Target Transmembrane and Ig Domain-Containing 1 Signaling to Augment Renal Tubular Injury.

  2023cites this paper
• Metabolomic Profiles, Ideal Cardiovascular Health, and Risk of Heart Failure and Atrial Fibrillation: Insights From the Framingham Heart Study

  2023cites this paper
• Qishen granules regulate intestinal microecology to improve cardiac function in rats with heart failure

  2023cites this paper
• Circulating metabolites improve the prediction of renal impairment in patients with type 2 diabetes

  2023cites this paper
• Identifying disease progression in chronic kidney disease using proton magnetic resonance spectroscopy.

  2023cites this paper
• Untargeted Metabolomics by Ultra-High-Performance Liquid Chromatography Coupled with Electrospray Ionization-Quadrupole-Time of Flight-Mass Spectrometry Analysis Identifies a Specific Metabolomic Profile in Patients with Early Chronic Kidney Disease

  2023cites this paper
• Kidney-specific metabolomic profiling in machine perfusate.

  2023cites this paper
• TRIMETHYLAMINE OXIDE - FACTOR IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND A POTENTIAL TARGET FOR DIETARY AND PHARMACOLOGICAL INTERVENTIONS.

  2023cites this paper
• Metabolomic Investigation of Blood and Urinary Amino Acids and Derivatives in Patients with Type 2 Diabetes Mellitus and Early Diabetic Kidney Disease

  2023cites this paper
• Nitric Oxide Precursors and Dimethylarginines as Risk Markers for Accelerated Measured GFR Decline in the General Population.

  2023cites this paper
• Kynurenine Pathway in Diabetes Mellitus—Novel Pharmacological Target?

  2023cites this paper
• The Role of Intestinal Flora and Its Metabolites in Heart Failure

  2023influential citation
• Gut microbiota-derived metabolite trimethylamine-N-oxide and stroke outcome: a systematic review

  2023cites this paper
• Metabolomic profiles in serum and urine uncover novel biomarkers in children with nephrotic syndrome

  2023cites this paper
• Exploration of Metabolomic Markers Associated With Declining Kidney Function in People With Type 2 Diabetes Mellitus

  2023cites this paper
• Blueberry, cranberry, raspberry, and strawberry as modulators of the gut microbiota: target for treatment of gut dysbiosis in chronic kidney disease? From current evidence to future possibilities.

  2023cites this paper
• Metabolomic and lipidomic landscape of porcine kidney associated with kidney perfusion in heart beating donors and donors after cardiac death.

  2023cites this paper
• Gut dysbiosis: Ecological causes and causative effects on human disease

  2023influential citation
• Circulating metabolites associated with kidney function decline and incident CKD: a multi-platform population-based study

  2023cites this paper
• Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: a systematic review.

  2023cites this paper
• Metabolic Rewiring and Communication: An Integrative View of Kidney Proximal Tubule Function.

  2023cites this paper
• Precision Medicine in Diabetic Kidney Disease: A Narrative Review Framed by Lived Experience

  2023cites this paper
• Tubular Dysfunction Impairs Renal Excretion of Pseudouridine in Diabetic Kidney Disease.

  2023cites this paper
• Trimethylamine N-oxide and kidney diseases: what do we know?

  2023influential citation
• N-óxido de trimetilamina e doenças renais: o que sabemos?

  2023influential citation
• A systematic review of metabolomic findings in adult and pediatric renal disease.

  2023cites this paper
• Urinary Metabolite Profile Predicting the Progression of CKD

  2023cites this paper
• Nuclear Magnetic Resonance-Based Metabolomics and Risk of CKD.

  2023cites this paper
• Associations of serum amino acids related to urea cycle with risk of chronic kidney disease in Chinese with type 2 diabetes

  2023cites this paper
• Kynurenines in polycystic kidney disease

  2022cites this paper
• Plasma Kynurenine: A Promising Marker for the Assessment of Renal Functions

  2022cites this paper
• Artemether Alleviates Diabetic Kidney Disease by Modulating Amino Acid Metabolism

  2022cites this paper
• Serum Trimethylamine N-Oxide Level Is Associated with Peripheral Arterial Stiffness in Advanced Non-Dialysis Chronic Kidney Disease Patients

  2022cites this paper
• Uromodulin and its association with urinary metabolites: the German Chronic Kidney Disease Study.

  2022cites this paper
• Metabolomics analysis of human plasma reveals decreased production of trimethylamine N‐oxide retards the progression of chronic kidney disease

  2022cites this paper
• Association of Proximal Tubular Secretory Clearance with Long-Term Decline in Cognitive Function

  2022cites this paper
• The Association of Plasma Trimethylamine N-Oxide with Coronary Atherosclerotic Burden in Patients with Type 2 Diabetes Among a Chinese North Population

  2022cites this paper
• Metabolomics of Arterial Stiffness

  2022cites this paper
• DMSO_A_339698 69..78

  2022cites this paper
• NAD+ Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease

  2022cites this paper
• Association between serum uric acid/HDL-cholesterol ratio and chronic kidney disease: a cross-sectional study based on a health check-up population

  2022cites this paper
• Metabolic flux between organs measured by arteriovenous metabolite gradients

  2022cites this paper
• Trimethylamine, a gut bacteria metabolite and air pollutant, increases blood pressure and markers of kidney damage including proteinuria and KIM-1 in rats

  2022cites this paper
• Glomerular filtration rate abnormalities in sickle cell disease

  2022cites this paper
• Blood Levels of Endocannabinoids, Oxylipins, and Metabolites Are Altered in Hemodialysis Patients

  2022cites this paper
• Effects of Buyang Huanwu Decoction on Intestinal Barrier, Intestinal Flora, and Trimethylamine Oxide in Rats with Heart Failure

  2022cites this paper
• Serum Metabolites and Kidney Outcomes: The Atherosclerosis Risk in Communities Study

  2022cites this paper
• Association of circulating Trimethylamine-N oxide with malnutrition and the risk of coronary artery disease in patients with maintenance hemodialysis.

  2022cites this paper
• The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression

  2022cites this paper
• Integrative phosphatidylcholine metabolism through phospholipase A_2 in rats with chronic kidney disease

  2022cites this paper
• TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review

  2022cites this paper
• Skeletal muscle metabolic responses to physical activity are muscle type specific in a rat model of chronic kidney disease

  2021cites this paper
• Urine metabolites for preoperative prediction of acute kidney injury after coronary artery bypass graft surgery.

  2021cites this paper